Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0344232 (blurred vision)
 2,072 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A 50-year-old woman was admitted because of severe exophthalmos associated with Graves disease. She underwent methimazole (MMI) and methylprednisolone pulse therapy against exophthalmos. She noticed photophobia and blurred vision 3 weeks after the start of pulse therapy and she was diagnosed as having uveitis. Methylprednisolone pulse therapy was performed again for both exophthalmos and uveitis, followed by daily administration of 20 mg of prednisolone and instillation of betamethasone for 2 weeks and the uveitis was improved. Western blot analysis confirmed that human T lymphotropic virus type 1 (HTLV-1) antibody was present in her serum. Propylthiouracil was substituted for MMI and HTLV-1-associated uveitis (HAU) has not recurred. Six months after the beginning of administration of PTU, anti-neutrophil cytoplasmic antibody-related vasculitis developed in the patient. We review 43 cases of HAU with Graves disease, including the present case, in the literature. Only 2 of 27 cases (except unknown cases) (7.4%) had Graves ophthalmopathy. To the best of our knowledge, there has been no investigation of HAU and Graves ophthalmopathy.
 ...
PMID:Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease. 1218 5

Ophthalmopathy is a common manifestation of autoimmune thyroid disease. Periorbital swelling, eyelid lag, exophthalmos, and impaired vision may occur. From 25% to 50% of patients with Graves' hyperthyroidism will have some features of ophthalmopathy. All of the clinically significant eye symptoms and findings among patients with Graves' ophthalmopathy can be traced to one of two phenomena: swelling in the retrobulbar space due to deposition of glycosaminoglycans (GAG) or restriction of extraocular muscle motion, which is attributed to initial swelling and later fibrosis. Patients with Graves' eye disease typically complain of ocular or periocular pain, lacrimation, photophobia, blurred vision, diplopia, or impaired perception of colour. On examination, they exhibit orbital congestion, proptosis, optic neuropathy, restricted gaze, divergent visual axis, corneal exposure, lid retraction, and periorbital edema. This paper describes the main clinical features of Graves' ophthalmopathy, in order to establish measurable and reproducible classifications that can be used in the surgery setting to record changes and to guide and assess therapy. Finally, we recommend the use of objective measurements for proptosis, extraocular movements, corneal alterations, and the optic nerve, using the clinical activity scale or a recorded change in objective measurements to document disease activity, and lastly, documenting the patients' perception of their disease status.
 ...
PMID:[Clinical manifestations of thyroid ophthalmopathy]. 1916 94